簡易檢索 / 詳目顯示

研究生: 曾耀群
Tseng, Yao-Chun
論文名稱: 應用醫療照護之失效模式與效應分析於醫療流程之改善
Applying HFMEA to Healthcare Process Improvement
指導教授: 蘇朝墩
Su, Chao-Ton
口試委員:
學位類別: 碩士
Master
系所名稱: 工學院 - 工業工程與工程管理學系
Department of Industrial Engineering and Engineering Management
論文出版年: 2009
畢業學年度: 97
語文別: 中文
論文頁數: 74
中文關鍵詞: 失效模式危害評估矩陣醫療照護失效模式與效應分析醫療照護失效模式與效應分析決策樹
外文關鍵詞: FMEA, HFMEA, hazard score matrix, HFMEA decision tree
相關次數: 點閱:2下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 近年來,國內發生醫療事故的情況層出不窮,病人視醫療服務為自身的權利,造成現今醫病雙方關係又產生新的變化。有鑑於此,自2001年起,為了降低風險及預先建立起管制方法以防止事故發生,美國醫療機構評鑑聯合會要求醫療照護單位每年至少選擇一項高風險醫療流程,執行預防性的風險評估分析作業。
    就我們所知,「事前預防勝於事後偵錯」,且醫療照護失效模式與效應分析是美國醫療機構評鑑聯合會支持醫界運用的分析評估方法。基於此概念,發展出以醫療照護失效模式與效應分析作為改善方法,藉由跨部門小組使用流程圖、危害評估矩陣和醫療照護失效模式與效應分析決策樹,以辨識及評估流程中潛在之失效點。本研究於醫療照護失效模式與效應分析決策樹之第五步驟將失效模式分類三種行動型態後,再將各失效模式分類出四大類型。並經由此分類,提供跨部門小組成員在最後可更加有效地提出適切的改善行動方案。
    本研究以台灣某醫院為研究對象,並針對各流程給予建議行動以供改善參考。此外,於四大分類之結果,相較於不同流程上有著不同的結果表現,除了針對人為因素的加強輔導之外,更強調管理體制的強化及改良,做為風險的預防對策。因此在各流程之改善行動建議上也提供此一方向作為研究之參考。


    第一章 緒論 1 1.1 研究背景 1 1.2 研究動機 2 1.3 研究目的 3 1.4 研究架構 3 第二章 文獻探討 5 2.1 失效模式與效應分析 5 2.1.1 FMEA發展歷史 5 2.1.3 FMEA之應用文獻 8 2.2 醫療照護失效模式與效應分析 10 2.2.1 HFMEA之發展歷史 10 2.2.2 HFMEA之執行步驟 12 2.2.3 HFMEA之應用文獻 14 第三章 HFMEA於醫療流程之應用 17 3.1 評選HFMEA主題 17 3.2 組成HFMEA團隊 18 3.3 繪製流程圖 19 3.4 執行危害分析 21 3.5 確認行動與結果量測 23 第四章 個案研究 26 4.1 個案背景 26 4.2 運用HFMEA方法於個案之改善 27 4.2.1 小兒運際運送流程HFMEA分析 27 4.2.2 成人院際運送流程HFMEA分析 35 4.2.3 成人院內運送流程HFMEA分析 45 4.2.4 化療給藥流程HFMEA分析 56 第五章 結論與建議 68 5.1 結論 68 5.2 建議 69 5.3 未來展望 71 參考文獻 72

    1. Adachi, W. and Lodolce, A. E., 2005, “Use of Failure Mode and Effects Analysis in Improving the Safety of i.v. Drug Administration,” American Journal of Health-System Pharmacy, Vol. 62, No. 9, pp. 917-920.
    2. Anthony, D., Chetty, V. K., Kartha, A., McKenna, K., DePaoli, M. R. and Jack, B., 2005, “Re-engineering the Hospital Discharge: An Example of a Multifaceted Process Evaluation,” Advances in Patient Safety, Vol. 2, pp. 379-394.
    3. Apkon, M., Leonard, J., Probst, L., Delizio, L. and Vitale, R., 2004, “Design of a Safer Approach to Intravenous Drug Infusions: Failure Mode Effects Analysis,” Quality and Safety in Health Care, Vol. 13, pp. 265-271.
    4. Arunajadai, S. G., Uder, S. J., Stone, R. B. and Tumer, I. Y., 2004, “Failure Mode Identification Through Clustering Analysis,” Quality and Reliability Engineering International, Vol. 20, pp. 511-526.
    5. Benjamin, D. V., 2003, “Reducing Medication Errors and Increasing Patient Safety: Case Studies in Clinical Pharmacology,” The Journal of Clinical Pharmacology, Vol. 43, No. 7, pp. 768-783.
    6. Burgmeier, J., 2002, “Failure Mode and Effect Analysis: an Application in Reducing Risk in Blood Transfusion,” Journal on Quality Improvement, Vol. 28, No. 6, pp. 331-339.
    7. Cassanelli, G., Mura, G., Fantini, F., Vanzi, M. and Plano, B., 2006, “Failure Analysis-assisted FMEA,” Microelectronics Reliability, Vol. 46, pp. 1795-1799.
    8. Coles, G., Fuller, B., Nordquist, K. and Kongslie, A., 2005, “Using Failure Mode Effects and Criticality Analysis for High-Risk Processes at Three Community Hospitals,” Journal on Quality and Patient Safety, Vol. 31, No. 3, pp. 132-140.
    9. Greenall, J., Walsh, D. and Wichman, K., 2007 “Failure Mode and Effects Analysis: a Tool for Identifying Risk in Community Pharmacies,” CPJ/RPC, Vol. 140, No. 3, pp. 191-193.
    10. Huang, G. Q., Nie, M. and Mak, K. L., 1999, “Web-based Failure Mode and Effect Analysis (FMEA),” Computers & Industrial Engineering, Vol. 37, pp. 177-180.
    11. Institute for Safe Medication Practices Canada., 2006, “Failure Mode and Effects Analysis (FMEA): Proactively Identifying Risk in Healthcare,” ISMP Canada Safety Bulletin, Vol. 6, Iss. 8.
    12. Joseph DeRosier, PE, CSP., Erik Stalhandske, MPP, MHSA., James P, Bagian, MD, PE., Tina Nudell, MS., 2002,“Using Health Care Failure Mode and Effect Analysis: The VA National Center for Patient Safety’s Prospective Risk Analysis System,”Joint Commission on Accreditation of Healthcare Organizations, Vol. 28, No. 5, pp. 248-265.
    13. Kim, G. R., Chen, A. R., Arceci, R. J., Mitchell, S. H., Kokoszka, K. M., Daniel, D. and Lehmann, C. U., 2006, “Error Reduction in Pediatric Chemotherapy: Computerized Order Entry and Failure Modes and Effects Analysis,” Archives of Pediatrics and Adolescent Medicine, Vol. 160, pp. 495-498.
    14. Kmenta, S. and Ishii, K., 2004, “Scenario-Based Failure Modes and Effects Analysis Using Expected Cost,” Journal of Mechanical Design, Vol. 126, pp. 1027-1035.
    15. Krouwer, J. S., 2004, “An Improved Failure Mode Effects Analysis for Hospitals,” Archives of Pathology and Laboratory Medicine, Vol. 128, pp. 663-667.
    16. Latino, R. J., 2004, “Optimizing FMEA and RCA Efforts in Health Care,” American Society for Healthcare Risk Management Journal, Vol. 24, No. 3, pp. 21-28.
    17. Linkin, D. R., Sausman, C., Santos, L., Lyons, C., Fox, C., Aumiller, L., Esterhai, J., Pittman, B. and Lautenbach, E., 2005, “Applicability of Healthcare Failure Mode and Effects Analysis to Healthcare Epidemiology: Evaluation of the Sterilizaiton and Use of surgical Instruments,” Healthcare Epidemiology, Vol. 41, pp. 1014-1019.
    18. McNally, K. M., Page, M. A. and Sunderland, V. B., 1997, “Failure-Mode and Effects Analysis in Improving a Drug distribution System,” American Journal of Health-System Pharmacy, Vol. 54, No. 2, pp. 171-177.
    19. Pillay, A. and Wang, J., 2003,“Modified Failure Mode and Effects Analysis Using Approximate Reasoning,” Reliability Engineering and System Safety, Vol. 79, pp. 69-85.
    20. Pollock, S., 2005, “Create a Simple Framework to Validate FMEA Performance,” Six Sigma Forum Magazine, pp. 27-34.
    21. Price, C. J. and Taylor, N. S., 2002, “Automated Multiple Failure FMEA,” Reliability Engineering and System Safety, Vol. 76, pp. 1-10.
    22. Reiling, J. G., Knutzen, B. L. and Stoecklein, M., 2003, “FMEA-the Cure for Medical Error,” Quality Progress, pp. 67-71.
    23. Rotondaro, R. G. and De Oliveira, C. L., 2001, “Using Failure Mode Effect Analysis (FMEA) to Improve Service Quality Service Operations Management,” Proceedings of the Twelfth Annual Conference of the Production and Operations management Society.
    24. Seyed-Hosseini, S. M., Safaei, N. and Asgharpour, M. J., 2006, “Reprioritization of Failures in a System Failure Mode and Effects Analysis by Decision Making Trial and Evaluation Laboratory Technique,” Reliability Engineering and System Safety, Vol. 91, pp. 872-881.
    25. Scipioni, A., Saccarola, G., Centazzo, A. and Arena, F., 2002, “FMEA Methodology Design, Implementation and Integration with HACCP System in a Food Company,” Food Control, Vol. 13, pp. 495-501.
    26. Wetterneck, T. B., Skibinski, K. A., Roberts, T. L., Kleppin, S. M., Schroeder, M. E., Enloe, M., Rough, S. S., Hundt, A. S. and Carayon, P., 2006, “Using Failure Mode and Effects Analysis to Plan Implementation of Smart i.v. Pump Technology,” American Journal of Health-System Pharmacy, Vol. 63, No. 16, pp. 1528-1538.
    27. Williams, E. and Talley, R., 1994, “The Use of Failure Mode Effect and Criticality Analysis in a Medication Error Subcommittee,” Hospital Pharmacy, Vol. 29, No. 4 pp. 331-332, 334-337, 339.
    28. 李金梅、任美珍、李宥樓譯 (2005),以客為尊的健康照護 (Customer-Driven Healthcare: QFD for Process Improvement And Cost Reduction),Ed. M. D. Chaplin and John Terninko著,經濟部中小企業處出版。
    29. 柯輝耀著 (2001),預防性失效分析/FMECA & FTA之應用,中華民國品質學會出版。
    30. 許國敏、莊秀文、莊淑婷著 (2006),病人安全管理與風險管理實務導引,華杏出版股份有限公司出版。

    無法下載圖示 全文公開日期 本全文未授權公開 (校內網路)
    全文公開日期 本全文未授權公開 (校外網路)

    QR CODE